Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical and Immunological Study of the Efficacy and Safety of Combined Treatment of Patients With Severe Herpes Simplex (HSV) Infection) by Acyclic Nucleoside Valacyclovir and Interferon Inducer Kagocel

NCT04664127 is registered in ClinicalTrials.gov with Nearmedic Plus LLC as lead sponsor.

NCT NCT04664127
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04664127 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical and Immunological Study of the Efficacy and Safety of Combined Treatment of Patients With Severe Herpes Simplex (HSV) Infection) by Acyclic Nucleoside Valacyclovir and Interferon Inducer Kagocel
Lead sponsor
Nearmedic Plus LLC
Phase
Observational
Overall status
Completed
Start date
October 30, 2017
Completion date
October 29, 2018
Enrollment
45 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

herpes, herpes genitalis, herpes oral, herpes simplex, herpes simplex 2